ADS Diagnostic Ltd shares today hit 5% upper circuit on BSE. Current market price of ADS Diagnostic shares on BSE is Rs 11.34 per share with gain of 5.00% in trade today. The company has a market capitalisation of Rs 2.55 crore. Its ROE is 31.24 and PE is 1.32. The company had recommended a final dividend of Re 0.12 per equity share of Rs 10 each.

Today it has fixed September 30, 2024 as the record date for final dividend of Re 0.12 per share. The company will hold its AGM on September 28, 2024. Check key details below:

ADS Diagnostic Sets Record Date For Final Dividend: As per the exchange filing of ADS Diagnostic dated September 25, 2024, “We would like to bring to your kind attention that in the said Board Meeting, the Board of Directors of the Company declared a final dividend of Rs. 0.12 (12%) per equity share of Rs. 10 each, Dividend amount 1.2, subject to approval by the shareholders at the ensuing Annual General Meeting (AGM). Please note that the Company has now decided that the record date for the purpose of determining the eligibility of shareholders for the final dividend shall be 30th September 2024.”

ADS Diagnostic AGM: The Annual General Meeting (AGM) of ADS Diagnostic Ltd will take place on September 28, 2024.

ADS Diagnostic Shares Performance: The 52-week high price of ADS Diagnostic Ltd shares on BSE is Rs 11.34 per share (as on 17/04/2014) and 52-week low price is Rs 11.34 (as on 17/04/2014), respectively.

What Is Upper Circuit? When a stock hits upper circuit, it implies the scrip has hit its maximum price in a trading session. Stock exchanges set the price limit of stock in an effort to control volatility and save traders from sudden movement in prices.

About: The Company, ADS Diagnostic Ltd., was incorporated on 23rd June 1984 as a Private Limited Company under the name and style of Indian Cancer Detection & Research Institute Pvt. Ltd., Subsequently the name of the Company was changed to ADS Diagnostic Ltd. The company was converted into a Public Limited Company on 1st November, 1985. The ADS Medical Systems is a Unit of ADS Diagnostic Ltd, according to its official website.

Disclaimer: The stock highlights the dividend and is not a recommendation to buy, sell or hold. We have not done fundamental or technical analysis and have no opinion on the stock mentioned. Neither, the author nor Greynium Information Technologies should be held liable for any losses. Please consult a professional advisor.

Story first published: Wednesday, September 25, 2024, 14:22 [IST]